Stockreport

Sanofi Advances Rare Disease And Immunology Pipeline With Multiple Phase 3 Wins [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Sanofi (ENXTPA:SAN) reported that its investigational therapy venglustat met all primary endpoints in a Phase 3 trial for type 3 Gaucher disease, a rare neurological co [Read more]